CD44 and breast cancer: A Systematic Review to Clarify the Prognostic Values of CD44 and CD44<sup>+</sup>CD24<sup>-</sup> Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead.